Comprehensive Solutions for Life Sciences
Tempus provides an integrated suite of solutions to help focus, accelerate, and de-risk clinical drug development.
Data Collaborations: Access DNA, RNA, H&E images, and other clinical, imaging, and molecular data to uncover new insights across the R&D continuum.
Cloud-native Analytics Platform: Tempus Lens enables fast identification of fit-for-purpose patient populations across hundreds of petabytes of data, with pre-built visualizations and cloud-based coding environments designed to surface actionable insights in minutes.
Biological Modeling: Tumor organoid drug screening services to generate multimodal data insights (phenotypic, molecular, clinical) for preclinical research.
Next-Generation Sequencing and CDx: Solid tissue, liquid biopsy, DNA, whole transcriptome RNA, MRD detection for research and CDx development.
Full-service CRO: Compass is optimized for biopharma and complex drug development in oncology.
Clinical Trials Network: Tempus TIME enables rapid patient identification and just-in-time site activation through a powerful integration of data, technology, and streamlined operations.
Prospective Evidence Generation: Tempus Studies delivers agile, prospective datasets which can include longitudinal genomic, transcriptomic, imaging, and clinical data.
AI-enabled Care Pathway Intelligence Platform: Tempus Next accelerates the adoption of evidence based care and increases adherence to clinical guidelines.
AI Algorithm Development and Deployment: Generate clinical insights without the need for an additional specimen through DNA, RNA, H&E images, or other health data.
...
More Info Less Info